Related Experiment Video
Updated: Aug 8, 2025
09:31
Native Chromatin Immunoprecipitation Using Murine Brain Tumor Neurospheres
Published on: January 29, 2018
7.7K
Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at
Allison R Pine1,2, Stefano M Cirigliano3, Richa Singhania3
1Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Research
|March 6, 2023
Summary
Researchers developed a glioblastoma cerebral organoid model to study tumor heterogeneity. This model revealed epigenetic changes and a shared cell population, offering new therapeutic targets for glioblastoma (GBM).
Area of Science:
- Neuroscience
- Cancer Biology
- Genomics
Background:
- Glioblastoma (GBM) exhibits significant intratumoral heterogeneity and cell state plasticity.
- Conventional models fail to accurately replicate GBM cellular states, impeding research into transcriptional regulation.
- The tumor microenvironment is crucial for modeling these complex GBM characteristics.
Purpose of the Study:
- To investigate the epigenetic underpinnings of glioblastoma cellular states using a novel cerebral organoid model.
- To identify gene-regulatory networks governing GBM cell state transitions.
- To discover potential therapeutic targets for genetically diverse GBMs.
Main Methods:
- Profiling chromatin accessibility in 28,040 single cells from five patient-derived glioma stem cell lines within a cerebral organoid model.
- Integrating paired epigenome and transcriptome data to analyze gene-regulatory networks.
- Examining tumor-normal host cell interactions within the organoid system.
Main Results:
- Identified epigenetic factors driving distinct GBM cellular states.
- Characterized dynamic chromatin changes associated with GBM cell state transitions, resembling early neural development.
- Discovered a conserved cellular compartment comprising neural progenitor-like and outer radial glia-like cells across different GBM tumors.
- Revealed insights into the transcriptional regulation program of GBM.
Conclusions:
- The glioblastoma cerebral organoid model effectively recapitulates GBM heterogeneity and plasticity.
- Specific epigenetic modifications and cell populations (radial glia-like) represent potential therapeutic targets.
- Understanding these mechanisms can lead to improved therapeutic strategies for a wide range of GBMs.
